RESULTS FOR : 'Artificial Intelligence'
Showing 1 to 4 of 4 results |    
Keyword Search
Show#
Show#
Results Category/Section
ARTIFICIAL INTELLIGENCE and biopharma R&D IT

"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise to improve the traditional drug target selection and R&D process."

LifeArc and Milner Therapeutics Institute announce a new partnership in artificial intelligence and machine learning for target discovery

LifeArc, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, have announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

sciNote to incorporate artificial intelligence into its electronic lab notebook

sciNote Manuscript Writer is the first add-on of its kind to aid researchers in drafting scientific papers

Adopting AI is essential for a sustainable pharma industry.

Advancements in technology, and in particular, developments in artificial intelligence (AI) are revolutionising the way that we live our lives. Up to now, we have used it to help us find the quickest route home or to search the Internet, but we now need to look much further.